| Literature DB >> 30337188 |
Matilde Rubio-Almanza1, Rosa Cámara-Gómez2, Juan Francisco Merino-Torres2.
Abstract
The prevalence of obesity has increased worldwide over the past decades. Obesity is associated with multiple comorbidities, such as type 2 diabetes, that generates a great impact on health and economy. Weight loss in these patients leads to glycemic control so it is a target to achieve. Lifestyle changes are not effective enough and recently other treatments have been developed such as bariatric/metabolic surgery, as well as drugs for type 2 diabetes and antiobesity drugs. The aim of this review is to compare the results in weight reduction and glycemic control of the different kinds of drugs with bariatric / metabolic surgery's results in type 2 diabetes.Entities:
Keywords: Antiobesity drugs; Bariatric surgery; Cirugía bariátrica; Cirugía metabólica; Clinical trials; Diabetes tipo 2; Ensayos clínicos; Fármacos para obesidad; Metabolic surgery; Obesidad; Obesity; Type 2 diabetes
Mesh:
Substances:
Year: 2018 PMID: 30337188 DOI: 10.1016/j.endinu.2018.08.003
Source DB: PubMed Journal: Endocrinol Diabetes Nutr (Engl Ed) ISSN: 2530-0180 Impact factor: 1.417